Composition:
Ginkgo biloba extract dry 120 mg (including flavonol glycosides) 26.4 mg Glycine 40 mg
Description:
Regulatory effect on blood vessels, reduces the tendency to dangerous formation of clots and blood clots in the veins and arteries, increases the brain's consumption of oxygen and glucose, antioxidant, tablets weighing 0.5 g
Contraindications:
Individual intolerance to components, pregnancy, breast-feeding.
Pharmachologic effect:
Biologically active substances of ginkgo biloba leaf extract:
- contribute to strengthening and increasing the elasticity of the vascular wall;
- improve the rheological properties of blood and, as a result, improves microcirculation, supply of the brain and peripheral tissues with oxygen and glucose.
A drug:
- improves cerebral circulation;
- has cerebroprotective properties;
- reduces the permeability of the vascular wall (decongestant effect - both at the level of the brain and at the periphery).
- normalizes metabolism in cells;
- prevents the aggregation of red blood cells;
- inhibits platelet activation factor;
- prevents the increase of fibrinolytic activity of blood;
- prevents the formation of free radicals and lipid peroxidation of cell membranes;
- has a dose-dependent regulatory effect on the vascular system, expands small arteries, increases venous tone, regulates blood vessels.
- increases the body's resistance to hypoxia, especially brain tissue, inhibits the development of traumatic or toxic cerebral edema.
Indications:
Supplements for improving cerebral and peripheral circulation.
- Discirculatory encephalopathy (consequences of stroke, traumatic brain injury, senile age), manifested by disorders of attention and / or memory, decreased intellectual ability, anxiety, fear, sleep disturbance;
- dementia, incl. with Alzheimer's disease;
- to improve memory and attention in young people;
- sensorineural disorders (dizziness, tinnitus, hypoacusia), senile macular degeneration, diabetic retinopathy;
- asthenic conditions: psychogenic, neurotic, due to traumatic brain damage;
- disorders of peripheral circulation and microcirculation, including arteriopathy of the lower extremities, Raynaud's syndrome.
Recommendations for use:
Adults take 1-2 tablets 3 times a day with meals.
Duration of admission is at least 3 months.
Reception is recommended to be repeated 2 times a year.